239 related articles for article (PubMed ID: 20825443)
21. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
22. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
24. Prolonged remission in a child with chronic myeloid leukemia following Parvo virus B19 (B19V) infection.
Kumar A; Moulik NR; Kishore J; Kumar A; Jain A
Indian J Med Microbiol; 2015; 33(3):432-4. PubMed ID: 26068352
[TBL] [Abstract][Full Text] [Related]
25. A pilot study on parvovirus B19 infection in paediatric haematological malignancies.
Kishore J; Sen M; Kumar A; Kumar A
Indian J Med Res; 2011 Apr; 133(4):407-13. PubMed ID: 21537094
[TBL] [Abstract][Full Text] [Related]
26. Clinical and hematological study for Parvovirus b19 infection in children with acute leukemia.
Zaki ME; Ashray RE
Int J Lab Hematol; 2010 Apr; 32(2):159-66. PubMed ID: 19261033
[TBL] [Abstract][Full Text] [Related]
27. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
Weseslindtner L; Aberle JH; Hedman L; Hedman K
J Infect Dis; 2017 Jan; 215(2):214-220. PubMed ID: 27789725
[TBL] [Abstract][Full Text] [Related]
28. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation.
Porignaux R; Vuiblet V; Barbe C; Nguyen Y; Lavaud S; Toupance O; Andréoletti L; Rieu P; Lévêque N
J Med Virol; 2013 Jun; 85(6):1115-21. PubMed ID: 23588740
[TBL] [Abstract][Full Text] [Related]
29. [Parvovirus B19 infection in patients with congenital blood coagulation disorders].
Aguilar Franco C; Lucía Cuesta JF; Ferrer Torres J; Omeñaca Teres M
Med Clin (Barc); 1997 May; 108(17):641-6. PubMed ID: 9312580
[TBL] [Abstract][Full Text] [Related]
30. Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities.
da Costa AC; Bendit I; de Oliveira ACS; Kallas EG; Sabino EC; Sanabani SS
Clin Microbiol Infect; 2013 Jan; 19(1):E31-E43. PubMed ID: 23167493
[TBL] [Abstract][Full Text] [Related]
31. Parvovirus B19 infection in Chile: markers of infection and immunity in patients with clinical symptoms.
Larrañaga C; León O; Díaz P; Miranda M; Norambuena X; Pérez M; Gaggero A
J Med Virol; 2007 Dec; 79(12):1927-34. PubMed ID: 17935173
[TBL] [Abstract][Full Text] [Related]
32. Incidence and progression of Parvovirus B19 infection and molecular changes in circulating B19V strains in children with haematological malignancy: A follow up study.
Jain A; Jain P; Kumar A; Prakash S; Khan DN; Kant R
Infect Genet Evol; 2018 Jan; 57():177-184. PubMed ID: 29170063
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
34. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.
Cassinotti P; Siegl G; Michel BA; Brühlmann P
J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
[TBL] [Abstract][Full Text] [Related]
36. Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study.
Würdinger M; Modrow S; Plentz A
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608818
[TBL] [Abstract][Full Text] [Related]
37. Human parvovirus B19 surveillance in patients with rash and fever from Belarus.
Yermalovich MA; Hübschen JM; Semeiko GV; Samoilovich EO; Muller CP
J Med Virol; 2012 Jun; 84(6):973-8. PubMed ID: 22499021
[TBL] [Abstract][Full Text] [Related]
38. Haematological consequences of parvovirus B19 infection.
Brown KE
Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):245-59. PubMed ID: 10942624
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
40. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions.
Slavov SN; Kashima S; Pinto AC; Covas DT
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):247-62. PubMed ID: 21585562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
